Omepra (Omeprazole)

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related gastrointestinal conditions.

• Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.
• Helicobacter pylori eradication regimens (as adjunct): improves eradication rates when combined with antibiotics.
• NSA‑induced gastropathy prophylaxis: lowers incidence of ulcer formation in at‑risk patients.

• Omeprazole selectively and irreversibly inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid production, it markedly reduces both basal and stimulated gastric acidity, allowing mucosal healing and symptom control.

Adverse reactions to omeprazole vary in frequency and severity.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea or abdominal discomfort: transient.
• Flatulence: occasional.
• Constipation: mild.
• Dry mouth: occasional.

Serious or Rare Side Effects

• Clostridioides difficile‑associated colitis: may present with severe diarrhea.
• Acute interstitial nephritis: renal function impairment.
• Hypomagnesemia: can cause muscle cramps or cardiac arrhythmia.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin reactions.
• Hepatotoxicity: elevated liver enzymes or jaundice.
• Bone fractures (with long‑term use): increased risk of hip, wrist or vertebral fractures.

When prescribing omeprazole, clinicians should consider several safety aspects.

• Assess renal and hepatic function: dose adjustment may be needed in severe impairment.
• Review concomitant medications: potential for drug‑drug interactions.
• Monitor long‑term users: watch for magnesium deficiency and bone health.
• Use the lowest effective dose: limit duration to the shortest period required.
• Pregnancy and lactation: evaluate risk‑benefit ratio before use.
• Store at below 25°C: keep in the original container, protect from moisture and heat.

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk.
• Atazanavir or other protease inhibitors: decreased absorption, loss of antiviral efficacy.
• Warfarin: enhanced anticoagulant effect, monitor INR closely.

Moderate Interactions (Monitor Closely)

• Digoxin: increased serum concentrations, monitor levels.
• Methotrexate (high‑dose): reduced clearance, watch for toxicity.
• Phenytoin: altered metabolism, may require dose adjustment.